Portfolio company
Metri
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biotechnology company develops organoid-based human models to create therapeutics for patients with uterine and endometrial diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Endogene.Bio
This company develops a biological data platform using menstrual blood to provide diagnostics and patient stratification tools for pharmaceutical firms and healthcare providers.
Endometrics
Endometrics develops non-invasive diagnostic tests using menstrual blood samples and genomic biomarkers to detect endometriosis for women and healthcare providers.
Matrubials
This biotechnology company develops milk-derived antibacterial therapeutics to treat infectious diseases like bacterial vaginosis for women.
iOrganBio
This company develops an artificial intelligence-guided manufacturing platform to produce engineered human cells and organoids for biopharmaceutical researchers and clinical partners.
Vitra Labs
The company develops a stem cell platform to produce eggs for patients undergoing fertility treatments without the use of hormones or donor tissue.
Organo-ID
The company develops 3D organoid models and drug response tests for cancer patients and pharmaceutical researchers to improve personalised medicine and treatment efficacy.
Freya Biosciences
This company develops microbial immunotherapies targeting the vaginal microbiome to treat infertility and other reproductive health conditions for women.
Vitra Bio
This biotechnology company develops in vitro fertilization technology and cell-based therapies to induce oogenesis outside the ovary for patients struggling with infertility.
